Home
About
Platform
Pipeline
CTRX 101
Publications
Team
News
Contact
Blog
This is your first post. Edit or delete it, then start writing!
Blog Page
Classic
Grid
Masonry
Timeline
Single Post
Single Post
Full Width
Left Sidebar
Right Sidebar
March 2, 2026
CounterX Therapeutics Announces Formation of Scientific Advisory Board with Leading Experts in Substance Use Disorders
October 29, 2025
CounterX Therapeutics Announces Publication Demonstrating CTRX-101, an Anti-Fentanyl Monoclonal Antibody Therapy, Reverses Fentanyl-Induced Overdose in Preclinical Model
October 10, 2025
An anti-fentanyl monoclonal antibody reverses fentanyl-induced apnea in pigs
